Home Company News Chemesis International – On the Move

Chemesis International – On the Move

Chemesis International – On the Move

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is on the move again with plans to add another 25,000 sq.ft. of manufacturing space in Cathedral City, California.  It is anticipated that this new facility will be up and running by Q2 2019. NEWS

The additional space will allow for expansion of the company’s finished goods which currently include beverages, edibles and other consumer goods.

The fully state compliant facility for manufacturing, packaging, distribution and transportation will provide direct product distribution to state licensed dispensaries.

This move, which will increase the company’s already strong presence in California, is a follow-up to Chemesis’ announcement in October 2018 of plans to enter into the edibles market.  The edibles which will include among other products, gummies, chews, chocolates, brownies, and cookies are expected to be launched this year.

With the continual activities to grow the market stake in California, Chemesis ‘expected annual revenue in that state alone is projected to reach $61.5 million by year four with a net income of $27.2 million. (Investment News Network: 2018 Article: Bringing Vertically-Integrated Cannabis to Puerto Rico and California) https://investingnews.com/company-profiles/chemesis-seed-to-sale-cannabis-company/

Given the cannabis market in California is projected to reach $7.7 billion by 2022, Chemesis is in a good position to continue to capitalize on the market through their own expansion plans.  (Cannabis Business Plan : California Cannabis Market) https://cannabusinessplans.com/california-cannabis-market/

This latest California expansion comes on the close heels of Chemesis’ acquisition in November 2018 of La Finca, a Colombian based cannabis company with access to over 1000 acres of cultivation land.  This move also includes a partnership with Colombia’s largest university, Universidad Nacional de Colombia for the development of seed strains.

In addition, operations in Puerto Rico continue to be monitored closely with an eye to further expansion in that territory.

With continual innovation and expansion, Chemesis is poised to become an important company to watch and one that I plan to keep on my radar.

Happy Investing!

Dr. Kal Kotecha



© 2018 Stock Trends Report/© 2010 Junior Gold Report


Stock Trends Report/Junior Gold Report Newsletter and website: Stock Trends Report Newsletter/Junior Gold Report Newsletter and website is published as a copyright publication of Stock Trends Report/Junior Gold Report (STR).  No Guarantee as to Content:  Although STR attempts to research thoroughly and present information based on sources we believe to be reliable, there are no guarantees as to the accuracy or completeness of the information contained herein (newsletter and website). Any statements expressed are subject to change without notice. It may contain errors and you should not make any investment decisions based on what you have read on here. STR, its associates, authors, and affiliates are not responsible for errors or omissions. By accessing the site and receiving this email, you accept and agree to be bound by and comply with the terms and conditions as set out herein. If you do not accept and agree to the terms you should not use the Stock Trends Report site or accept this email. Consideration for Services: STR, it’s editor, affiliates, associates, partners, family members, or contractors may have an interest or position in the featured companies, as well as sponsored companies which compensate STR as such our opinions are biased. We may hold potions in and trade these stocks of the companies we profile and as such our opinions are biased. STR and its’ owner and affiliates/associates may buy/sell and trade the featured companies from time to time. STR has been paid by the companies. Thus, multiple conflicts of interest exist. Therefore, information provided here within should not be construed as a financial analysis but rather as an advertisement. Conduct your own due diligence: The author’s views and opinions regarding the companies featured in report(s) are his/her own views and are based on information that he/she has researched independently and has received, which the author assumes to be reliable. You should never base any buying/selling/trading decisions off of our emails, newsletter, website, videos or any of our published materials. STR aims to provide information and often stock ideas but are by no means recommendations. The ideas and companies featured are highly speculative and you could lose your entire investment – consult a licensed financial advisor if you are considering investing in any of the featured companies. Subscribers/readers are encouraged to conduct their own research and due diligence. The companies mentioned are high risk and considered penny stocks that contain a high risk of volatility, therefore consult your investment advisor and do your own due diligence before purchasing. Never base any investment decision on information contained from our emails, newsletter, website, videos or any of our published materials. No Offer to Sell Securities: STR is not a registered broker dealer, investment advisor, financial analyst, stock picker, investment banker or other investment professional. STR is intended for informational, educational and research purposes only. It is not to be considered as investment advice. No statement or expression of any opinions contained in this report constitutes an offer to buy or sell the shares of the companies mentioned herein. Links: STR may contain links to related websites for stock quotes, charts, etc. STR is not responsible for the content of or the privacy practices of these sites. Information contained herein was extracted from public filings, profiled company websites, and other publicly available sources deemed reliable. Information in this report was taken on or before writing and dissemination and may not be updated. Do you own due diligence as information and events can and do change. Published reports may reference company websites or link to company websites and we disclaim and responsibility for the content and accuracy of any such information or website. Release of Liability: By reading the newsletter/website and/or watching videos by STR, you agree to hold STR, its associates, sponsors, affiliates, and partners harmless and to completely release them from any and all liabilities due to any and all losses, damages, or injuries (financial or otherwise) that may be incurred.


Forward Looking Statements
Except for statements of historical fact, certain information contained herein constitutes forward-looking statements. Forward looking statements are usually identified by the use of certain terminology, including “will”, “believes”, “may”, “expects”, “should”, “seeks”, “anticipates”, “has potential to”, or “intends’ or by discussions of strategy, forward looking numbers or intentions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results or achievements to be materially different from any future results or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts, and include but are not limited to, estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to the effectiveness of the Company’s business model; future operations, products and services; the impact of regulatory initiatives on the Company’s operations; the size of and opportunities related to the market for the Company’s products; general industry and macroeconomic growth rates; expectations related to possible joint and/or strategic ventures and statements regarding future performance. Stock Trends Report does not take responsibility for the accuracy of forward looking statements and advises the reader to perform their own due diligence on forward looking numbers or statements.